For many international companies, the successful listing of their security represents an important milestone. It’s a sign of recognition, prestige and success, demonstrating to the market a desire to be open and transparent. Continue reading “Benefits of Cross-Trading in the United States”
As the home for thousands of small-cap companies, we meet with issuers daily to help them work through the challenges associated with operating as a successful public company. For each of these companies there are numerous aspects to consider – from how to take the company public and raise capital, to developing an effective IR program and targeting the right types of investors. Our goal is simple – to help alleviate much of the cost, time and complexity associated with being a public company.
That’s why we’ve developed a straightforward guide in collaboration with IR Magazine.
We often hear questions from foreign issuers and their respective exchanges surrounding the decision to pursue secondary trading in the U.S. Many harbor the misconception that cross-trading in the U.S. will lead to a loss of trading volume and drain in liquidity from their primary home market. Continue reading “New Independent Study: Benefits for International Companies Trading on OTCQX”
Cromwell Coulson’s Lifetime Achievement Award and Dedication to STANY
April 19, 2018
The Security Traders Association of New York (STANY) honored OTC Markets Group CEO Cromwell Coulson with its 5th Annual Award for Lifetime Achievement and Dedication to STANY at its 82nd annual conference. Cromwell joined CNBC’s Bob Pisani for a Fireside Chat to talk about the evolution of OTC Markets Group and the contributions of industry professionals that have leveraged their knowledge for the benefit of both the trading community and investors.
Late last year, OTC Markets Group published a new Stock Promotion policy, along with Best Practices for public companies. These policies outline OTC Markets efforts to establish best standard practices, improve market transparency and better address the problem of fraudulent stock promotion. Continue reading “New Promotion Risk Flag Among the Latest Data Points to Increase Transparency and Investor Protection”
Over the past 20 years, the reputation and recognition of the OTC markets has grown. Part of that positive transformation has come from technology, both at OTC Markets Group and from the broker-dealer community, that has fostered a vibrant, data-driven, electronic trading market. Continue reading “2018 Regulatory Initiatives & Targeted Rulemaking: Improving Transparency, Focusing on Market Efficiency”
Issues Facing Small Cap Issuers
As the market operator where thousands of small and micro-cap securities trade, we occasionally hear from issuers and their investors who are frustrated when brokers won’t deposit their stock. While this is generally perceived to be an OTC issue, the reality is that this affects privately issued shares on all public markets, including national exchanges. Continue reading “Why Can’t I Deposit my Shares?”
The OTC equity market operates within a unique, often complex regulatory environment. While much of the securities industry focuses solely on federal laws and regulation, the companies, broker-dealers, investors and others comprising the OTC market must understand the impact of state “Blue Sky” laws as well. Continue reading “Understanding Blue Sky Laws”
We recently announced the 2018 OTCQX® Best 50. Now In its 4th year, our annual ranking highlights the top 50 U.S. and international companies traded on the OTCQX Best Market, based on an equal weighting of one-year total return and average daily dollar volume growth. The companies featured in the Best 50 were ranked based upon their performance during the 2017 calendar year.